Drug intelligence / Profile preview

Sulphur

Development stage: Preclinical
Administration: Oral

Overview

Sulphur is a homoeopathic medicine that has been evaluated for its usefulness in managing Schizophrenia and Atopic Dermatitis. In homoeopathic practice, it is typically prescribed in various potencies, such as 30C, after repertorization and consultation of Materia Medica. Studies have suggested its positive role in improving symptoms in patients with these conditions.

Beyond the preview

Go deeper on Sulphur.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sulphur.

Explore the full profile